ASRRF:OTC-ASR Nederland N.V (USD)

COMMON STOCK | Other | OTC

Last Closing Price

USD 31.87

Change

0.00 (0.00)%

Market Cap

USD 6.03B

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

ASR Nederland N.V. provides various insurance and non-insurance products and services to private and business customers in the Netherlands and internationally. It operates through Non-Life, Life, Banking and Asset Management, Distribution and Services, Holding and Other, and Real Estate Development segments. The company offers non-life insurance products, including motor vehicle, fire, travel and leisure, transport, liability, agricultural, construction motorized vehicles, and construction all risk and assistance insurance products; self-employed disability, sickness leave, and group disability insurance products; and health insurance products comprising basic health insurance and supplementary health insurance products. It also provides life insurance products, such as individual life and group pensions, and funeral insurance products. In addition, the company offers bank and deferred annuities, savings accounts, and retail investments; and investment property management services, as well as distributes insurance contracts and offers financial intermediary services. Further, it engages in the property development business. ASR Nederland N.V. offers its products under the a.s.r., De Amersfoortse, Ditzo, Europeesche Verzekeringen, and Ardanta brand names. The company was formerly known as Fortis Verzekeringen Nederland N.V. and changed its name to ASR Nederland N.V. in October 2008. ASR Nederland N.V. is headquartered in Utrecht, the Netherlands.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-09-22 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SSNLF Samsung Electronics Co., Ltd

N/A

USD15,011.80B 9.00 N/A
DISPF Disco Corporation

N/A

USD3,369.71B 18.60 -488.90
BMYMP Bristol-Myers Squibb Company P..

N/A

USD1,803.92B 4,888.89 N/A
CHKDJ Chesapeake Energy Corporation ..

N/A

USD1,315.84B N/A N/A
BAMKL Bank of America Corporation

N/A

USD267.26B 9.28 N/A
UNLNF Unilever N.V

N/A

USD158.01B 24.49 N/A
LLOBF Lloyds Banking Group plc 9.25%..

N/A

USD134.80B N/A N/A
AZSEY Allianz SE

N/A

USD103.32B 11.82 N/A
NCRRP NCR Corporation 5.5% PFD CNV A

N/A

USD100.40B 707.44 N/A
RNFTF Public Joint Stock Company Ros..

N/A

USD82.94B 10.30 N/A

ETFs Containing ASRRF

Symbol Name Weight Mer Price(Change) Market Cap
EUSC WisdomTree Trust - Wisdom.. 0.00 % 0.58 %

+0.30 (+0.84%)

USD0.05B
ISCF iShares Trust - iShares M.. 0.00 % 0.40 %

+0.16 (+0.41%)

USD0.19B
CES1:LSE iShares VII Public Limite.. 0.00 % 0.58 %

+295.00 (+1.26%)

USD0.85B
CEUS:LSE iShares VII Public Limite.. 0.00 % 0.58 %

N/A

USD0.65B
EUSV:LSE SPDR MSCI Europe Small Ca.. 0.00 % 0.30 %

N/A

USD0.04B
UB69:LSE UBS (Lux) Fund Solutions .. 0.00 % 0.33 %

N/A

USD0.13B
MMS:PA Lyxor Index Fund - Lyxor .. 0.00 % 0.40 %

+3.98 (+1.08%)

USD0.26B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.40 %

+3.70 (+1.00%)

USD0.24B
SXRJ:F iShares VII Public Limite.. 0.00 % 0.58 %

+2.75 (+1.00%)

USD0.83B
UEFD:F UBS (Lux) Fund Solutions .. 0.00 % 0.33 %

+1.40 (+1.09%)

USD0.13B
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.30 %

+0.55 (+1.20%)

USD0.10B
LGWU:XETRA Lyxor Index Fund - Lyxor .. 0.00 % 0.40 %

+3.85 (+1.04%)

USD0.26B
SXRJ:XETRA iShares VII Public Limite.. 0.00 % 0.58 %

+2.90 (+1.06%)

USD0.84B
UEFD:XETRA UBS (Lux) Fund Solutions .. 0.00 % 0.33 %

+1.30 (+1.01%)

USD0.13B
ZPRX:XETRA SSgA SPDR ETFs Europe II .. 0.00 % 0.30 %

+0.68 (+1.50%)

USD0.10B
1388:TSE UBS (Lux) Fund Solutions .. 0.00 % 0.33 %

-220.00 (-1.34%)

USD0.12B

Market Performance

  Market Performance vs.
Industry/Classification (Other)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.59% 54% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.59% 51% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 22.92% 54% F 75% C
Risk Adjusted Return 28.76% 55% F 51% F
Market Capitalization 6.03B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Other)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 9.20 N/A N/A N/A N/A
Price/Book Ratio 38.86 N/A N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA 15.00 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 11.35% N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio 58.81% N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta -5.36 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike